Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PharmVar GeneFocus: NAT2-Genetic Variation and Updated Nomenclature.

Clinical pharmacology and therapeutics·2025
Same author

Arylamine N-acetyltransferase 1 expression predicts glucose dependence and mitochondrial bioenergetics in cancer cells.

Biochimica et biophysica acta. Molecular cell research·2025
Same author

Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration.

ACS pharmacology & translational science·2024
Same author

The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction.

Pharmacological reviews·2024
Same author

A PEGylated liposomal formulation of prochlorperazine that limits brain exposure but retains dynamin II activity: A potential adjuvant therapy for cancer patients receiving chemotherapeutic mAbs.

Nanomedicine : nanotechnology, biology, and medicine·2024
Same author

Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats.

Molecular pharmaceutics·2023
Same journal

Zingerone ameliorates ovarian impairment by regulating steroidogenesis and apoptosis in letrozole-treated mouse.

Endocrinology·2026
Same journal

Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesity.

Endocrinology·2026
Same journal

Long Non-Coding RNAs Mediate Endocrine Signaling and Resistance in Prostate Cancer.

Endocrinology·2026
Same journal

Repeated Chemogenetic Activation of C1 Catecholamine Neurons Reduces Subsequent Glucoprivic Responses and Mimics HAAF.

Endocrinology·2026
Same journal

Postnatal exposure to maternal hypothyroidism leads to developmental delay and metabolic dysregulations in male mice.

Endocrinology·2026
Same journal

Discovery proteomics identification of factors contributing to gonadotropin β expression.

Endocrinology·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Nanoparticles for molecular imaging--an overview.

Rodney F Minchin1, Darren J Martin

  • 1School of Biomedical Sciences, University of Queensland, St. Lucia, Queensland 4072, Australia. r.minchin@uq.edu.au

Endocrinology
|December 18, 2009
PubMed
Summary
This summary is machine-generated.

Nanoparticles are revolutionizing molecular imaging by enabling noninvasive visualization of physiological changes. This technology holds significant potential for improving disease diagnosis and monitoring treatment efficacy.

More Related Videos

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jun 17, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Area of Science:

  • Nanotechnology
  • Molecular Imaging
  • Biomedical Engineering

Background:

  • Molecular imaging quantifies in vivo physiological changes using noninvasive detection probes.
  • Recent advancements in nanotechnology have significantly accelerated molecular imaging research.
  • Innovative nanoparticle development enhances the versatility of various imaging modalities.

Purpose of the Study:

  • To review recent advances in nanoparticle-based molecular imaging.
  • To highlight the application of nanoprobes for in vivo imaging of specific cells and tissues.
  • To discuss the potential of nanoparticles in disease diagnosis and treatment monitoring.

Main Methods:

  • Review of current literature on nanoparticles for molecular imaging.
  • Analysis of nanoparticle capabilities in detecting and quantifying biological processes.
  • Discussion of challenges and future directions in nanoparticle-based molecular imaging.

Main Results:

  • Nanoparticles offer enhanced capabilities for molecular imaging, enabling visualization at cellular and tissue levels.
  • Developed nanoprobes show promise for measuring disease-related biological processes.
  • The application of nanoparticles can aid in monitoring treatment responses in vivo.

Conclusions:

  • Nanoparticle development is a key driver in the rapid advancement of molecular imaging.
  • These nanoprobes have considerable potential to improve disease diagnosis and personalize treatment strategies.
  • While much of the technology is still experimental, its clinical impact is anticipated to be substantial.